Contact this trialFirst, we need to learn more about you.
Chemotherapy
mDCF + Avelumab for Esophago-gastric Adenocarcinoma
Recruiting2 awardsPhase 2
Montréal, Quebec
This trial is testing a new cancer treatment that combines avelumab with a modified chemotherapy regimen. The goal is to see if this new treatment can improve pathologic complete response rates and disease-free survival rates in patients with stomach, EGJ, or lower esophageal cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.